Organogenesis Inc.
Company Information

150 Dan Rd Ste 3
Canton, MA, 02021 United States
(781) 575-0198

Top 3 Competitors

Unlock more access to Hoover’s!

  • Build customized email lists 24/7, based on your best customer profile.
  • Learn more about the companies you want to sell to. Hoover’s has reports on 85+ million companies and 900 industries. 65,000 data points are updated each day.
  • Get real insight written by real people – exclusive research and reviews by our in-house Editorial staff.
  • We can deliver our data to your desktop, to Excel, direct to your CRM, into your custom app, or via mobile.

Call (866) 473-3932 today to get started with a FREE TRIAL!


Organogenesis Inc. Company Profile

Organogenesis has the skinny on replacement tissue. Its flagship product, Apligraf, is a human skin substitute approved to treat diabetic foot ulcers and venous leg ulcers caused by poor circulation. It has delivered more than 500,000 units of Apligraf for patient treatment. Rejection-resistant Apligraf is bio-engineered using living skin cells and has been used to treat chronic open wounds. Founded in 1985, the company is developing a next-generation of the material using all human components via its VCT technology. It also offers a line of biomaterials used in a range of surgical procedures to seal or reconstruct soft tissue and develops regenerative technologies in the area of cosmetic skin rejuvenation.